CN110423264B - 一种基于活化酯高效制备棕榈酰三肽-5的方法 - Google Patents
一种基于活化酯高效制备棕榈酰三肽-5的方法 Download PDFInfo
- Publication number
- CN110423264B CN110423264B CN201910789414.XA CN201910789414A CN110423264B CN 110423264 B CN110423264 B CN 110423264B CN 201910789414 A CN201910789414 A CN 201910789414A CN 110423264 B CN110423264 B CN 110423264B
- Authority
- CN
- China
- Prior art keywords
- cbz
- lys
- pal
- val
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000002148 esters Chemical class 0.000 title claims abstract description 50
- 229940094912 PALMITOYL TRIPEPTIDE-5 Drugs 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 claims abstract description 67
- 239000000047 product Substances 0.000 claims abstract description 52
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000021314 Palmitic acid Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 221
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 108
- 238000006243 chemical reaction Methods 0.000 claims description 91
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 60
- 238000001035 drying Methods 0.000 claims description 49
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 48
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 48
- 239000000706 filtrate Substances 0.000 claims description 48
- 238000003756 stirring Methods 0.000 claims description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 39
- ARBOVOVUTSQWSS-UHFFFAOYSA-N hexadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCC(Cl)=O ARBOVOVUTSQWSS-UHFFFAOYSA-N 0.000 claims description 39
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 32
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-hydroxy-Succinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 30
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-Dimethylaminophenol Substances CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 claims description 24
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 24
- 239000004472 Lysine Substances 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 20
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 19
- ZUSSTQCWRDLYJA-UHFFFAOYSA-N N-Hydroxy-5-norbornene-2,3-dicarboximide Chemical compound C1=CC2CC1C1C2C(=O)N(O)C1=O ZUSSTQCWRDLYJA-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 15
- 239000002585 base Substances 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 11
- 229960004295 valine Drugs 0.000 claims description 11
- CTSLXHKWHWQRSH-UHFFFAOYSA-N Oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 10
- 239000012298 atmosphere Substances 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- 125000002252 acyl group Chemical group 0.000 claims description 9
- 238000005660 chlorination reaction Methods 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 9
- 238000000967 suction filtration Methods 0.000 claims description 9
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N Chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- UHZYTMXLRWXGPK-UHFFFAOYSA-N Phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 5
- HCUYBXPSSCRKRF-UHFFFAOYSA-N Diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 claims description 4
- FAIAAWCVCHQXDN-UHFFFAOYSA-N Phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M Potassium bicarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 4
- UCPYLLCMEDAXFR-UHFFFAOYSA-N Triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 4
- YGYAWVDWMABLBF-UHFFFAOYSA-N phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 4
- 239000011736 potassium bicarbonate Substances 0.000 claims description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 4
- 229940094025 potassium bicarbonate Drugs 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 239000001184 potassium carbonate Substances 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 239000001187 sodium carbonate Substances 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 2
- 238000005063 solubilization Methods 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 150000001263 acyl chlorides Chemical class 0.000 abstract description 4
- 238000010511 deprotection reaction Methods 0.000 abstract description 3
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract description 2
- 238000005984 hydrogenation reaction Methods 0.000 abstract description 2
- 238000011031 large scale production Methods 0.000 abstract description 2
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract description 2
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 230000001681 protective Effects 0.000 abstract description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 42
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 30
- 229910052938 sodium sulfate Inorganic materials 0.000 description 30
- 235000011152 sodium sulphate Nutrition 0.000 description 30
- 239000007787 solid Substances 0.000 description 29
- 238000009987 spinning Methods 0.000 description 25
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 18
- 238000007792 addition Methods 0.000 description 17
- 229960001701 Chloroform Drugs 0.000 description 15
- OKKJLVBELUTLKV-MZCSYVLQSA-N cd3od Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 238000005303 weighing Methods 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 210000003491 Skin Anatomy 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 229960005188 collagen Drugs 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 239000005457 ice water Substances 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 102000003425 EC 1.14.18.1 Human genes 0.000 description 2
- 108060008724 EC 1.14.18.1 Proteins 0.000 description 2
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 description 2
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000003712 anti-aging Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000002708 enhancing Effects 0.000 description 2
- 230000001815 facial Effects 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002087 whitening Effects 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 1
- 210000002752 Melanocytes Anatomy 0.000 description 1
- 108020004999 Messenger RNA Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 210000002536 Stromal Cells Anatomy 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 238000005039 chemical industry Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920002106 messenger RNA Polymers 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000001172 regenerating Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910789414.XA CN110423264B (zh) | 2019-08-26 | 2019-08-26 | 一种基于活化酯高效制备棕榈酰三肽-5的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910789414.XA CN110423264B (zh) | 2019-08-26 | 2019-08-26 | 一种基于活化酯高效制备棕榈酰三肽-5的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110423264A CN110423264A (zh) | 2019-11-08 |
CN110423264B true CN110423264B (zh) | 2020-12-01 |
Family
ID=68415836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910789414.XA Active CN110423264B (zh) | 2019-08-26 | 2019-08-26 | 一种基于活化酯高效制备棕榈酰三肽-5的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110423264B (en.) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111004306B (zh) * | 2019-12-31 | 2020-09-25 | 山东济肽生物科技有限公司 | 棕榈酰三肽-5的液相合成方法 |
CN113461774A (zh) * | 2021-08-25 | 2021-10-01 | 深圳瑞德林生物技术有限公司 | 棕榈酰三肽-1的制备方法 |
CN114891063B (zh) * | 2022-05-20 | 2023-06-13 | 浙江湃肽生物股份有限公司 | 一种棕榈酰三肽-1的液相合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1625150T3 (pl) * | 2003-05-08 | 2007-05-31 | Dsm Ip Assets Bv | Tripeptydy i ich pochodne do stosowania w kosmetyce w celu poprawy struktury skóry |
JP2015510934A (ja) * | 2012-03-22 | 2015-04-13 | プレシジョン ダーマトロジー インコーポレイテッドPrecision Dermatology, Inc. | シクロデキストリンに基づくマイクロエマルション、およびその皮膚科使用 |
FR3052453B1 (fr) * | 2016-06-14 | 2018-05-18 | Sederma | Peptide, composition le comprenant et utilisations notamment cosmetiques |
-
2019
- 2019-08-26 CN CN201910789414.XA patent/CN110423264B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110423264A (zh) | 2019-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110423264B (zh) | 一种基于活化酯高效制备棕榈酰三肽-5的方法 | |
EP2231621B1 (en) | Process for preparing n-substituted hydroxypyrimidinone carboxamides | |
EP3342777B1 (en) | Benzyl compound | |
EP2873677A1 (en) | Method of producing self-assembling peptide derivative | |
CN109476684A (zh) | 新型呫吨保护剂 | |
EP3412665B1 (en) | Suvorexant intermediates and preparation methods thereof | |
CN111253287A (zh) | 液相汇聚式合成索马鲁肽侧链的方法 | |
CN103804469B (zh) | 卡非佐米中间体的制备方法 | |
CN113150066B (zh) | 蓝铜胜肽的合成方法 | |
CN104356197A (zh) | 一种卡非佐米中间体及其制备方法,以及一种卡非佐米的制备方法 | |
CN104379558B (zh) | 利用谷氨酸衍生物和羟基苯胺或羟基被保护的羟基苯胺合成拉马琳以及拉马琳前体的方法 | |
EP2247573B1 (en) | Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydrazinium)propionate esters and their use for 3-(2,2,2-trimethylhydrazinium)propionate dihydrate preparation | |
CN106565607B (zh) | 一种l-肌肽的合成方法 | |
CN111454180A (zh) | 一种索马鲁肽侧链中间体及其制备方法 | |
CN106946724B (zh) | 单胺基抑制剂类中间体2-乙酰氨基-2-苄基丙二酸单乙酯的合成方法 | |
CN109369779B (zh) | 一种他替瑞林的合成方法 | |
CN106146614A (zh) | 一种rgd三肽的制备方法 | |
CN105418737A (zh) | 一种短瓣花环肽a的固相合成方法和应用 | |
CN106554301B (zh) | 一种沙格列汀关键中间体的制备方法 | |
CN109824553B (zh) | 2–((叔丁氧基羰基)氨基)乙基-1-磺酸及其制备方法 | |
CN109574860A (zh) | 一种制备维兰特罗的方法 | |
CN112094224B (zh) | 一种带保护基的3-取代-5-氨基哌啶的制备方法 | |
CN113527245B (zh) | 一种芦荟松的合成方法及其用途 | |
CN107698663B (zh) | 一种维洛丝肽的液相合成方法 | |
CN111233685B (zh) | 一种外消旋d/l-叔亮氨酸的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |